Dolak JA

Language: English
References: 21
Page: 93-96
PDF size: 75.29 Kb.

Text Extraction

EPIDEMIOLOGY AND CLINICAL PRESENTATION
Pheochromocytoma (PCC) is a rare neuroendocrine tumor which may be characterized by a “rule of 10” - 10% familial, 10% extra-adrenal, 10% childhood onset, 10% malignant and 10% bilateral(1-3). More specifically.

REFERENCES

1. Williams DT, Dann S, Wheeler MH. Phaeochromocytoma - views on current management. Eur J Surg Oncol 2003;29:483-90.

2. Bullough AS, Karadia S, Watters M. Phaeochromocytoma: an unusual cause of hypertension in pregnancy. Anaesthesia 2001;56:43-6.

3. Lyman DJ. Paroxysmal hypertension, pheochromocytoma, and pregnancy. J Am Board Fam Pract 2002;15:153-8.

4. Ahn JT, Hibbard JU, Chapa JB. Atypical presentation of pheochromocytoma as part of multiple endocrine neoplasia IIa in pregnancy. Obstet Gynecol 2003;102:1202-5.

5. Dugas G, Fuller J, Singh S, Watson J. Pheochromocytoma and pregnancy: a case report and review of anesthetic management. Can J Anesth 2004;51:134-8.

6. Ahlawat SK, Jain S, Kumari S, Varma S, Sharma BK. Pheochromocytoma associated with pregnancy: case report and review of the literature. Obstet Gynec Survey 1999;54:728-37.

7. Ross EJ, Griffith DNW. The clinical presentation of pheochromocytoma. Q J Med 1989;71:485-96.

8. Kudva YC, Sawka AM, Young WF. Clinical review 164: the laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrin Metab 2003;88:4533-39.

9. Neumann HPH, Berger DP, Sigmund G, Blum U, Schmidt D, Parmer RJ, Volk B. Kirste G. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. New Engl J Med 1993;329:1531-38.

10. Schenker JG, Granat M. Pheochromocytoma and pregnancy-an updated appraisal. Aust NZ J Obstet Gynecol 1982;22:1-10.

11. Hermayer KL, Szpiech M. Diagnosis and management of pheochromocytoma during pregnancy: a case report. Am J Med Sci 1999;318:186-9.

12. Poopalalingham R, Chin EY. Rapid preparation of a patient with pheochromocytoma with labetolol and magnesium sulfate. Can J Anesth 2001;48:876-80.

13. Roizen MF. Anesthetic implications of concurrent diseases. In Miller RD, ed. Anesthesia, 4th edition New York, Churchill Livingstone, 1994;903-1014.

14. Boutros AR, Bravo EL, Zanettin G, Straffon RA. Perioperative management of 63 patients with pheochromocytoma. Cleve Clinic J Med 1990;57:613-7.

15. James MFM. Use of magnesium sulfate in the anesthetic management of phaeochromocytoma: a review of 17 anaesthetics. Br J Anaesth 1989;62:616-23.

16. Hamilton A, Sirrs S, Schmidt N, Onrot J. Anaesthesia for pheochromocytoma in pregnancy. Can J Anesth 1997;44:654-7.

17. Roizen MF, Horrigan RW, Koike M, Eger EI, Mulroy MF, Frazer B, Simmons A, Hunt TK, Thomas C, Tyrell B. A prospective, randomized trial of four anesthetic techniques for resection of pheochromocytoma. Anesthesiology 1982;57:A43.

18. James MF, Cronje L. Pheochromocytoma crisis: the use of magnesium sulfate. Anesth Analg 2004;99:680-6.

19. Altura BM, Altura BT. Role of magnesium ions in contractility of blood vessels and skeletal muscles. Mag Bulletin 1982;1a:102-14.

20. James MFM, Beer RE, Esser JD. Intravenous magnesium sulfate inhibits catecholamine release associated with tracheal intubation. Anesth Analg 1989;68:772-6.

21. Mayer DB, Miletich DJ, Feld JM, Albrecht RF. The effects of magnesium salts on the duration of epinephrine-induced ventricular tachyarrhythmias in anesthetized rats. Anesthesiology 1989;71:923-28.